-
Company Insights
Innovation and Patenting activity of Pilgrim~s Pride Corp Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Pilgrim~s Pride Corp Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Sector Analysis
Global Savory Snacks Sector Overview – Market Characteristics and Shopping Behavior driving Innovation in the sector
Overall, the savory snack sector will see an increase in value and volume between 2019-2023. However, this growth trajectory will differ from the forecasts from 2019 before the COVID-19 outbreak took place. The volume growth for the sector is forecast to be slower than anticipated, while the impact on value grow is expected to be more limited. This report outlines the market trends and consumer behavior impacting the savory snacks and what implications these may have on the industry's future....
-
Product Insights
Guillain-Barre Syndrome Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Guillain-Barre Syndrome Global Clinical Trials Review, H2, 2017" provides an overview of Guillain-Barre Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Guillain-Barre Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Guillain-Barre Syndrome Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Guillain-Barre Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Guillain-Barre Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Guillain-Barre Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Guillain-Barre Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Guillain-Barre Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Consumer Insights
Key Differences Across Consumer Groups during COVID-19 Lockdown for weeks 1-8 (Consumer Survey Insights)
The COVID-19 pandemic has drastically altered consumer behavior, paving the way for new consumer groups to emerge. For many, it has had a precautionary impact, prompting consumers to tighten their budgets, stockpile products, and retreat to familiar and trustworthy brands. Simultaneously, lockdown measures are encouraging certain consumers to embrace technology, upskill, and to be more experimental and indulgent with their purchases. This report is part of the GlobalData COVID-19 Survey Insights series, which tracks changes in consumer sentiment, lifestyles, attitudes,...
-
Sector Analysis
Saudi Arabia 2020 – Long Term Opportunities in the Middle East’s Biggest Market – MEED Insights
Saudi vision disrupted by Covid-19 but goals remain the same On 26 March 2020, King Salman bin Abdulaziz al-Saud chaired an emergency summit of G20 leaders to address the devastation being caused by the coronavirus (Covid-19) pandemic. The crisis meeting came three weeks after Riyadh upset the global economic order when it said that it was increasing oil production to record levels following the collapse of the agreement between the Opec+ group of oil producers to cap oil output to...